UltraSight™ Advances AI-Enabled Workflows in Cardiac Critical Care
BOSTON, MA, UNITED STATES, February 25, 2026 /EINPresswire.com/ -- UltraSight™, a leader in AI-guided cardiac imaging workflows, today announced U.S. Food and Drug Administration (FDA) clearance of PVAD IQ, an imaging tool used with the company’s …